Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Debatin, Klaus-Michael  [Clear All Filters]
2024
Schneider M, Potthoff A-L, Karpel-Massler G, Schuss P, Siegelin MD, Debatin K-M, Duffau H, Vatter H, Herrlinger U, Westhoff M-A. The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumours. Mol Oncol. 2024.
2020
Hoenig M, Roesler J, Seidel MG, Albert MH, Hauck F, Maecker-Kolhoff B, Eiz-Vesper B, Kleinschmidt K, Debatin K-M, Jacobsen E-M, et al. Matched Family Donor Lymphocyte Infusions as First Cellular Therapy for Patients with Severe Primary T-cell Deficiencies. Biol Blood Marrow Transplant. 2020.
Wildermann C, Alosaimi M, Liebenehm S, Jacobsen E, Barth TFE, Möller P, Debatin K-M, Schulz A, Sirin M, Abosoudah IF, et al. Successful hematopoietic stem cell transplantation in a 4-1BB deficient patient with EBV-induced lymphoproliferation. Clin Immunol. 2020:108639.
2019
Posovszky C, Sirin M, Jacobsen E, Lorenz M, Schwarz K, Schmidt-Choudhury A, Rothoeft T, Schuetz C, Hönig M, Debatin K-M, et al. Persisting enteropathy and disturbed adaptive mucosal immunity due to MHC class II deficiency. Clin Immunol. 2019.
2015
Schneider M, Ströbele S, Nonnenmacher L, Siegelin MD, Tepper M, Stroh S, Hasslacher S, Enzenmüller S, Strauss G, Baumann B, et al. A paired comparison between glioblastoma 'stem cells' and differentiated cells. Int J Cancer. 2015.
Ströbele S, Schneider M, Schneele L, Siegelin MD, Nonnenmacher L, Zhou S, Karpel-Massle G, Westhoff M-A, Halatsch M-E, Debatin K-M. A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy. PLoS One. 2015;10(6):e0131670.
2013
Saxena S, Wahl J, Huber-Lang MS, Stadel D, Braubach P, Debatin K-M, Beltinger C. Generation of Murine Sympathoadrenergic Progenitor-Like Cells from Embryonic Stem Cells and Postnatal Adrenal Glands. PLoS One. 2013;8(5):e64454.